1 2 Mouse hepatitis virus (MHV) infection is found commonly in laboratory mice and 3 this virus has been known to cause various diseases such as subclinical infection, enteritis, 4 hepatitis, and encephalitis. Serological tests are used commonly to diagnose MHV infection. 5 Complete MHV virions have been used primarily as antigens for serological diagnosis to date. 6
or polytropic. Polytropic strains disseminate from the initial site of replication in the 7 respiratory epithelium to neural, hepatic, vascular, and lymphatic tissues. Replication of 8 enterotropic strains is limited generally to replication within the intestinal tract and these 9 strains cause subclinical infection in adult mice. In contrast, polytropic strains are more likely 10 to cause more severe diseases with clinical symptoms (Baker, 1998) . Since MHV is one of the 11 most prevalent viruses in laboratory mice (Jacoby and Lindsey, 1997), it is important to detect 12 this virus in mice colonies by appropriate and sensitive screening tests during routine health 13 surveillance programs. Conversely, cross-reactivity between antibodies present in sera and nonspecific antigens used 20 in the test may yield a false positive result. Therefore, the use of purified antigens such as 21 recombinant proteins and synthesized antigenic peptides derived from pathogens will make 22 serological assays more specific and sensitive. MHV comprises at least three proteins: the 23 envelope glycoprotein designated as the spike (S) protein, the envelope membrane (M) 1 protein, and the nucleocapsid (N) protein (de Vries et The N protein consists of three domains conserved domains among the strains, which are 6 separated by two variable regions (Parker and Masters, 1990) . Several monoclonal antibodies 7 against the S, N, and M proteins were reported previously, indicating that these proteins are 8
immunogenic (Fleming et al., 1983; Kubo et al., 1994; Nelson et al., 2000; Stohlman et al., 9 1994; Stühler et al., 1991) . Therefore, these proteins are potential antigens for serological 10 diagnosis. 11
In this study, the antigenicity of the peptides derived from the MHV N protein was 12 demonstrated by using anti-MHV antisera and peptide array membrane, on which a set of 13 overlapping peptides covering the entire N protein was synthesized. The results showed that 14 16 antigenic linear sequences existed in the N protein. In these antigenic sequences, two sites 15 coding amino acids 24-38 (ILKKTTWADQTERGL) and 357-372 16 (RFDSTLPGFETIMKVL) of the N protein are strongly antigenic to anti-MHV antisera 17 derived from mice infected naturally. ELISA performed using these peptides was specific and 18 could detect anti-MHV antisera with higher sensitivity, than a commercial ELISA. These Care and Use Committee (IACUC), Nagoya City University, for screening and eradication of 7 MHV infection, the mice were euthanized and sera were obtained. Normal mice sera were 8 acquired from BALB/c, C57BL/6N, and DBA/2 mice obtained from SLC (Shizuoka, Japan). 9
These sera were derived from the samples obtained for routine screening during a health 10 surveillance program in the animal facility as per the guidelines of IACUC of Graduate 11 School of Veterinary Medicine, Hokkaido University. 12 the plate was incubated for 1 h at 37 ºC. After washing the well three times with PBS-Tween 6 20, 200 µl of the HRP-conjugated anti-mouse IgG diluted to 1:10,000 was added to the wells 7 and incubated for 1 h at 37 ºC. After washing the well three times with PBS-Tween 20, 200 µl 8 of 1.5 mg/ml o-phenylenediamine with 0.01% H 2 O 2 was added to each well and incubated for 9 10 min at 37 ºC. Following this, 50 µl of 6 N H 2 SO 4 was added and OD was measured at 450 10 nm using a plate reader. 11 To determine antigenic peptides for detecting anti-MHV antibodies, B-cell epitope 22 mapping of the MHV N protein was performed using the peptide array membrane. This array 23 membrane comprised 446 spots, which consisted of 10-mer peptides obtained by a single 1 amino acid shift, to produce a complete overlapping set of the N protein. Sera from mice that 2 were infected accidentally with MHV were incubated with the peptide array membrane. These 3 mice were confirmed to be positive using commercial ELISA for detecting anti-MHV 4 antibodies. As shown in Fig. 1 , the IgG antibodies in the sera, bound specifically to the 5 peptides on the spots, were detected. The serum used in Fig. 1 contained antibodies that 6 recognized at least four rows of spots, positioned at 27-29, 84-86, 183-187, and 362-366. 7
This result indicates the presence of four antigenic sites in the MHV N protein that are B-cell 8 linear epitopes. In contrast, no significant intensity was observed when sera from control mice 9 were used (data not shown). Sera from seven mice infected with MHV were then analyzed 10 with the same method. The chemiluminescence intensity of each spot was measured, and the 11 mean values are shown in the graph (Fig. 2) . Highest intensity was observed around the 28th 12 spot, on which a peptide consistent with amino acids 28-37 of the MHV N protein was 13 synthesized. A similar intensity was observed at the 362nd spot consistent with the intensity 14 observed at the sequence position 362-371. The peptides on the spots with an intensity higher 15 than 2.0 in Fig. 2 were defined as antigenic, and therefore, as B-cell linear epitopes. Sixteen 16 B-cell epitopes in the MHV N protein were found, and their position and sequence are shown 17
in Table 1 . The B-cell epitopes of the MHV N protein from MHV seen in Fig. 2 and Table 1  23 were expected to be antigens for serological diagnosis of MHV infection. To examine 1 whether these epitopes were appropriate for diagnosis, we developed an ELISA using the values decreased as the dilution increased ( Fig. 3, upper graph) . In contrast, the OD values 9 of normal sera were almost the same as those without sera. In the case of the MHV N 357-10 372 peptide, a similar result was seen ( Fig. 3, lower graph) . These results indicate that both 11 the MHV N peptides could be employed as specific antigens for detecting anti-MHV 12 antibodies. 13 To evaluate whether ELISA using the MHV-N peptides could be employed for 18 diagnosis, its immunoreactivity was examined using sera from the MHV-contaminated colony 19 that comprised mice infected accidentally with MHV and their cage mates. When sera from 20 eight control mice were used, the mean and the SD were as follows: 0.113 and 0.025 for the 21 MHV-N 24-39 peptides, and 0.181 and 0.023 for the MHV-N 357-372 peptides ( Table 2) . 22
The means and SD of OD values from the 15 mice maintained in the MHV-contaminated 23 colony are also given in Table 2 . The mean OD values of sera from mice in 1 MHV-contaminated colony were significantly higher than that from control mice. 2 Furthermore, these sera were evaluated by both commercial ELISA and ELISA using the 3 MHV-N peptides. As shown in Table 2 , the cutoff OD values of ELISA using MHV-N 4 peptides for MHV-positive sera were determined to be the mean + 2 SD from the control mice. 5
All control samples were negative in each ELISA (Table 3) ELISA were also positive in ELISA performed using the two peptides (data not shown). 10 Furthermore, the positive/negative frequency was significantly different between the mice in 11 the control and MHV-contaminated colonies when using ELISA using each MHV-N peptides . 12 In contrast, according to the chi-square test results, the positive/negative frequency of sera 13 from mice in the MHV-contaminated colony was not significantly different between 14 commercial ELISA and ELISA using the MHV-N peptides. These results indicate that the 15 ELISA performed using peptides from the N protein is as specific as the commercial ELISA 16 for the detection of MHV infection. 17 Table 1 . Because sera used for epitope mapping in this study 3 were derived from MHV-infected C57BL/6 mice, the same strain used in the study by 4 Stohlman et al., this result is considered to be reasonable. In addition, some epitopes that have 5 not been reported as yet were found in the present result, e.g., amino acids 150-159, 307-325, 6 335-346, and 357-373. In particular, the 357-373 amino acid segment was a strong antigenic 7 site in this study. The present results indicate that the approach using peptide array was very 8 efficient for screening the antigenic sites in the entire N protein to identify B-cell epitopes. In In this study, two sites corresponding to amino acids 24-39 and 357-372 of the N 13 protein were selected as ELISA antigens. As shown in Fig. 3 and Table 2 , ELISA using the 14 MHV-N 24-39 or MHV-N 357-372 peptides showed no nonspecific cross-reaction to normal 15 sera and was able to show specific reaction to anti-MHV antisera. The positive/negative 16 frequency was significantly different between mice from the control and MHV-contaminated 17 colonies when ELISA was performed with each MHV-N peptides (Table 3) . Furthermore, 18 from this ELISA, not only all MHV-positive sera but also some MHV-negative sera 19 diagnosed by commercial MHV ELISA were detected to be positive (data not shown). In 20 contrast, the antigen in commercial ELISA used in this study was the complete MHV virus 21 (Kagiyama et al., 1990) . These results indicate that the MHV-N 24-39 and MHV-N 357-372 22 peptides are as specific as the complete MHV virus for serological diagnosis of MHV 23 infection, and suggest that the ELISA using these peptides is more sensitive than commercial 1 ELISA. In addition, the utilization of peptides as antigens, compared to the complete MHV as 2 used in commercial ELISA, gives us the advantage in quality control, preparation, and 3 economy of ELISA products. However, the positive/negative frequency of sera from mice in 4 the MHV-contaminated colony was not significantly different between commercial ELISA 5 and ELISA using the MHV-N peptides. In addition, the reactivity of sera from various mice 6 strains was not examined by ELISA using the MHV-N peptides. Further studies are necessary 7 for validation of sensitivity and specificity of the two peptides to sera from mice in the 8 MHV-contaminated colony. 9
The sequence of the three carboxyl-terminal residues in the MHV-N 24-39 peptide 10 (GLN) is polymorphic among the strains of MHV. For example, this sequence is substituted 11 into GPN in polytropic MHV-1, MHV-3, and MHV-A59 strains and into AGN in polytropic 12 MHV-S and enterotropic MHV-Y strains (Parker and Masters, 1990) . Therefore, it is 13 necessary to examine whether this peptide is reactive to antisera against various MHV strains. 
